| 英文别名 |
2-(Naphthalen-1-ylmethyl)-4,5-dihydro-1H-imidazole;Naphazoline;Antan;Clearine;Nafazolina;Naphthizine;2-(naphthalen-1-yl)methyl-4,5-dihydro-1H-imidazole;2-Imidazoline, 2-(1-naphthylmethyl)- (7CI, 8CI);4,5-Dihydro-2-(1-naphthalenylmethyl)-1H-imidazole (ACI);Naphazoline (6CI);2-(1-Naphthalenylmethyl)-2-imidazoline;2-(1-Naphthylmethyl)-2-imidazoline;2-[(Naphthalen-1-yl)methyl]-4,5-dihydro-1H-imidazole;Antigaimorit;Colirio Alfa;Euboral Oftalmico;Imidin;MeSH ID: D009278;Naphthazoline;Nephazoline;Rhinazine;CHEMBL1706;Privine (Salt/Mix);SCHEMBL34532;Naphazolinum;HMS2090D15;2-(Naphthyl-(1')-methyl)imidazolin [German];L000878;KBio2_001455;Nadaplatin;2-(1-Naphthylmethyl)-4,5-dihydro-1H-imidazole;Tox21_113645;Naphazolinum [Latin];NINDS_000456;SBI-0051454.P003;2-Naphthalen-1-ylmethyl-4,5-dihydro-1H-imidazole; hydrochloride;Prestwick2_000046;cid_11079;DivK1c_000456;S01GA01;Prestwick0_000046;BRD-K77641333-003-25-5;BRD-K77641333-003-05-7;NAPHAZOLINE [MART.];Naphazolinum (Latin);KBioSS_001455;.alpha.-Naphthylmethyl imidazoline;Spectrum5_001424;alpha-Naphthylmethyl imidazoline;Q415433;Spectrum2_001054;DB06711;Nafazolin (TN);A840596;NCGC00024349-03;2-(1-naphthylmethyl)-4,5-dihydro-1H-imidazole;Naphazoline;BRN 0151864;2-(Naphthyl-(1')-methyl)imidazolin;835-31-4;Prestwick3_000046;KBio2_004023;BSPBio_000171;NAPHAZOLINE [MI];5-23-08-00293 (Beilstein Handbook Reference);NAPHAZOLINE [INN];2-(1-Naphthylmethyl)-4,5-dihydro-1H-imidazole #;Ciba 2020/R;CAS-550-99-2;NCGC00016506-02;CS-0034952;2-(alpha-Naphthylmethyl)-imidazoline;NCGC00016506-03;NAPHAZOLINE [WHO-DD];2-Imidazoline, 2-(1-naphthylmethyl)-;Naphazolinum [INN-Latin];AKOS000295230;Naphazoline [INN:BAN];NCGC00016506-04;NAPHAZOLINE [VANDF];DTXSID3048449;Prestwick1_000046;Naphazolinum (INN-Latin);GTPL5509;VS-03410;CHEMBL761;Nafazoline;UNII-H231GF11BV;FT-0725973;10061-11-7;EINECS 212-641-5;R01AA08;Sanorin (Salt/Mix);CCG-250339;BDBM50001922;SPBio_001008;AB00053505_14;CNIIGCLFLJGOGP-UHFFFAOYSA-N;EN300-16752;Z56762888;KBio1_000456;NCGC00016506-01;KBio2_006591;2-(1-naphthalenylmethyl)-4,5-dihydro-1H-imidazole;BPBio1_000189;CAS-835-31-4;SPBio_002092;KBioGR_000595;Spectrum_000975;AB00053505-12;AB00053505_13;DTXCID90198485;NCGC00016506-05;Nafazolin;H231GF11BV;CHEBI:93363;AB00053505-11;R01AB02;Spectrum4_000068;Enamine_000333;Nafazoline [Spanish];NAPHAZOLINE (MART.);Naphazoline (INN);Tox21_113058;D08253;IDI1_000456;2-(.alpha.-Naphthylmethyl)-imidazoline;HY-111326;Spectrum3_000513;BSPBio_002065;Nafazolina [DCIT];BRD-K77641333-003-15-6;NS00003424;1H-Imidazole, 4,5-dihydro-2-(1-naphthalenylmethyl)-;KBio3_001565;HMS1394P03;4,5-Dihydro-2-(1-naphthylmethyl)imidazole;NAFAZAIR;BRD-K77641333-003-26-3;BRD-K77641333-003-27-1;DB-050155;AK-968/41090774;BBL012612;STK300042;G77792 |
